PHARMACEUTICAL CARE FOR PATIENTS OF UNIFIED HEALTH SYSTEM WITH SEVERE ACNE: A HEALTH SERVICE IN ACADEMIC ENVIROMENT
DOI:
https://doi.org/10.14450/2318-9312.v31.e3.a2019.pp219-226Keywords:
pharmaceutical services, isotretinoin, Unified Health SystemAbstract
Acne is a cutaneous, genetic-hormonal disease that causes the formation of comedones, papules, and pustules in the region of the face and thorax. The present study evaluated the impact of Pharmaceutical Care on patients of Unified Health System, receiving free isotretinoin for the treatment of severe acne in a health service developed in a public university pharmacy inserted in the Specialized Component of Pharmaceutical Care. A descriptive, retrospective and quantitative study was carried out, based on the analysis of the pharmacotherapeutic follow-up records, pharmaceutical interventions and laboratory tests documented in internal records of patients assisted by the Pharmacy School of the Federal University of Piauí from November 2015 to July 2017. The records of 23 patients in which 34 types of adverse drug reactions were detected, besides four pharmaceutical interventions, predominantly related to the risk of drug interactions. The results highlight the notoriety of the initiative to implant this type of service in an
academic locus for the training of new health professionals, in addition to the benefits of pharmaceutical follow-up for patients with severe acne.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish in this journal agree to the following terms:
- Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Licença Creative Commons Attribution which allows the sharing of work with acknowledgment of authorship and initial publication in this journal.
- Authors are authorized to take additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (e.g. publish in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
- Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and Citation of published work (See O Efeito do Acesso Livre ).